Navigation Links
Sickle Cell Blood Test Might Predict Severity of Disease
Date:3/2/2012

FRIDAY, March 2 (HealthDay News) -- Researchers report they have developed a blood test that can predict which sickle cell patients are most likely to experience the most severe symptoms of the disease.

When the blood illness is at its worst, patients can suffer intense pain, internal organ damage and shortened lives.

While about 13 million people worldwide are thought to have the disease, which is caused by a genetic mutation, it's not well understood.

"We still don't have effective enough therapies, and we don't have a good feel for how the disease manifests itself differently in different people," Sangeeta Bhatia, a professor of health sciences and technology and electrical engineering and computer science at Massachusetts Institute of Technology in Boston, said in a news release from the institute. "When a patient has high cholesterol, you can monitor their risk for heart disease and response to therapy with a blood test. With sickle cell disease, despite patients having the same underlying genetic change, some suffer tremendously while others don't, and we still don't have a test that can guide physicians in making therapeutic decisions."

Bhatia and colleagues developed a test that measures the flow of samples of blood to determine the possible prognosis of sickle cell patients. The idea is to measure how badly blood flow has been disrupted by sickle-shaped blood cells. Normal blood cells are round in shape.

The findings are especially important because they can provide insight into how patients are responding to treatments such as blood transfusions or no treatment at all, said Dr. Patricia Oneal, co-director of the Center of Sickle Cell Disease at Howard University in Washington, D.C. Currently existing tests provide a "constrained view," Oneal said.

The research "will be crucial for future drug development in sickle cell disease," Oneal said, and gives patients information about whether they may need to take action to prevent vessel-clogging problems.

The researchers have applied for a patent for technology used in the test.

The study appears in the March 1 issue of the journal Science Translational Medicine.

More information

For more about sickle cell disease, try the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCES: Patricia Oneal, M.D., co-director, Center of Sickle Cell Disease, Howard University, Washington D.C.; Science Translational Medicine, news release, March 1, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Sickle Cell Disease Patients Seek Acute Pain Care Repeatedly
2. Low blood oxygen may lead to heart defects in children with sickle cell disease
3. Sickle Cell Disease Tied to Cognitive Difficulties
4. New study suggests sickle cell disease may affect brain function in adults
5. NHLBI to hold workshop on health consequences of sickle cell trait
6. Stroke prevention study in children with sickle cell anemia, iron overload stopped early
7. Sickle cell patients should be better monitored for constipation prevention
8. Sickle cell treatment developed at LA BioMed enters Phase 3 clinical trial
9. Georgia Tech hosts sickle cell disease symposium
10. 2 studies provide insight into stroke risk and prevention in young sickle cell anemia patients
11. Sickle Cell May Be Hidden Danger to Young Athletes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sickle Cell Blood Test Might Predict Severity of Disease
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement ... Vice President of North American Capital Sales at HTG Molecular . ... in the commercialization of the HTG EdgeSeq system and associated reagents in North America. ...
(Date:6/24/2016)... FL (PRWEB) , ... June 24, 2016 , ... Finally, ... common after venous procedures, dermaka cream can be incorporated into the post-surgical treatment plans ... minor surgical procedures. , dermaka cream is very effective for bruising and causes ...
(Date:6/24/2016)... AZ (PRWEB) , ... June 24, 2016 , ... SpiritQuest ... the heart of West Sedona, surrounded by famous vortex sites: Cathedral Rock, Airport Mesa, ... from partner properties – the Lodge at Sedona as well as the Sedona Rouge, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... , June 23, 2016 , ... Thursday, July 7, 2016 , , , , LOCATION: , ... , , , , EXPERT PANELISTS:  , , , Frost ... Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh ... The global pharmaceutical industry is witnessing an exceptional era. Several ...
(Date:6/23/2016)... Pa. , June 23, 2016 The ... in an outpatient dialysis facility.  Treatments are usually 3 ... 6 hours per visit, including travel time, equipment preparation ... a patient, but especially grueling for patients who are ... of a skilled nursing and rehabilitation centers for some ...
Breaking Medicine Technology: